| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/09/2008 | WO2007100590A3 Methods for treating cellulite |
| 10/09/2008 | WO2007098479A3 Localized insulin delivery for bone healing |
| 10/09/2008 | WO2007098283A3 Use of antagonists of maif receptor complex molecules and neurotrophic factors for treatment of neurological diseases and disorders |
| 10/09/2008 | WO2007095151A3 Nerve regeneration employing keratin biomaterials |
| 10/09/2008 | WO2007089805A3 Anti-hypertrophic effects and inotropic effects of picot |
| 10/09/2008 | WO2007067616A3 Uses of myostatin antagonists |
| 10/09/2008 | WO2006116423A3 Compositions and methods for cancer immunotherapy |
| 10/09/2008 | WO2006108051A3 Compositions and methods relating to alzheimer's disease |
| 10/09/2008 | US20080249179 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
| 10/09/2008 | US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid |
| 10/09/2008 | US20080249129 Compositions and Methods for Treatment of Protein Misfolding Diseases |
| 10/09/2008 | US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder |
| 10/09/2008 | US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide |
| 10/09/2008 | US20080249060 Nucleoside derivatives for treating hepatitis c virus infection |
| 10/09/2008 | US20080249057 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 10/09/2008 | US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 10/09/2008 | US20080249039 Modified Short Interfering Rna (Modified Sirna) |
| 10/09/2008 | US20080249031 Of (3S)-3-[N (N'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid; liver fibrosis |
| 10/09/2008 | US20080249030 Age Inhibitors |
| 10/09/2008 | US20080249029 Administering (S)-N-Methyl-D-phenylalanyl-N-[4-[(aminoiminomethyl)aminol-1-(2-benzothiazolylcarbonyl)butyl-L-prolinamide as a protease activated receptor-2 modulator |
| 10/09/2008 | US20080249028 Thyrotropin-Releasing Hormone Analogs and Method of Use |
| 10/09/2008 | US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249026 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING alpha3beta1 INTEGRINS |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249024 Peptides facilitating or inhibiting a nterograde transport |
| 10/09/2008 | US20080249023 Topical, intravenous, or iontophoretic administration of a phosphate buffered polypeptide sequence, TRKKLFHIFHATIRSR (PAD-1.17); cutaneous or pulmonary presenting anthrax antidotes; biological warfare |
| 10/09/2008 | US20080249022 Systemic or local administration of a lipopolysaccharide binding polypeptide; neutralizes microbial toxins and allows natural host defence mechanisms to control spread of infection; otitis media; antibiotic resistance |
| 10/09/2008 | US20080249021 Biologically active peptides and their use for repairing injured nerves |
| 10/09/2008 | US20080249020 Human Growth Hormone Treatment Methods |
| 10/09/2008 | US20080249019 Chronic obstructive pulmonary disease, asthma; polypeptide comprising a cytotoxin, a selective targeting domain, and a translocation domain |
| 10/09/2008 | US20080249018 Exendin Analog Formulations |
| 10/09/2008 | US20080249017 Pharmaceutical formulations of ghrh molecules |
| 10/09/2008 | US20080249016 Aong with parathyroid hormone or parathyroid homone related peptides; hypercalcemia; side effect reduction; improved bioresorption |
| 10/09/2008 | US20080249015 Prophylaxis of influenza A infections; hypoglycemic agents; obesity; bulimia nervosa |
| 10/09/2008 | US20080249014 Micro(dia)filtration of a cell homogenate, extracting the retenate using a buffer solution containing at least one detergent, ion exchange, hydroxyapatite column chromatography; Borrelia lipoproteins, membrane proteins; industrial scale |
| 10/09/2008 | US20080249013 Immunogenic fragment of a Cripto fusion protein that is reactive with an antibody or T-cell that reacts with a given polypeptide sequence; polynucleotides, expression vectors, host cells, T-cell lines; diganosis, prevention, treatment of lung, colon, colorectal and breast cancers |
| 10/09/2008 | US20080249012 INCREASING LIFE SPAN BY MODULATION OF Smek |
| 10/09/2008 | US20080249011 Use of Mgc4504 |
| 10/09/2008 | US20080249010 Method Of Inducing Apoptosis In Lymphoid Cells |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080249008 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor |
| 10/09/2008 | US20080249007 Lysine residue of analog acylated with a diacid; substituted for an amino acid residue in [N-epsilon(17-carboxyheptadecanoic acid)20 exendin-4(1-39)-amide; hyperglycemia, type 2 diabetes, impaired glucose tolerance, type 1 diabetes, obesity, hypertension, syndrome X, dyslipidemia, cognitive disorders |
| 10/09/2008 | US20080249006 Pharmaceutical Preparation for the Treatment of Shock |
| 10/09/2008 | US20080249005 Use of Dm43 and Its Fragments as Matrix Metalloproteinases Inhibitor |
| 10/09/2008 | US20080249004 Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity |
| 10/09/2008 | US20080249003 Compounds Inhibiting the Binding of Sap for Treating Osteoarthritis |
| 10/09/2008 | US20080249002 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 10/09/2008 | US20080249001 Agents that alleviate side-effects caused by chemotherapy agents |
| 10/09/2008 | US20080249000 Oil in water emulsion, dispersoid, hydrophobic of essential oils, oil-soluble flavors, colors, flavors, vitamins, polyunsaturated fatty acids, animal oils, vegetable oils, sucrose acetate isobutyrate, triglycerides; disperse hydrophobic material in hydrophilic in hydrophobic solvent |
| 10/09/2008 | US20080248999 Amylin formulations |
| 10/09/2008 | US20080248998 Glyceryl stearate or glyceryl palmitostearate to mask bad flavor of drugs; anti-bacterial, antifungal, metronidazole, anti-parasitic, nivaquine, antiviral, anti-cancer, analgesics, non-steroidal anti-inflammatories, anti-tussives, psychotropic, steroids, anti-histamines, anti-allergic agents |
| 10/09/2008 | US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners |
| 10/09/2008 | US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 10/09/2008 | US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter |
| 10/09/2008 | US20080248994 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration |
| 10/09/2008 | US20080248993 Oxidized or superoxidized modified isoform of T beta 4; neutral, non-polar, hydrophobic or non-oxidizing amino acid substituent is leucine, valine, isoleucine, alanine, phenylalanine, proline; induce terminal deoxynucleotidyl transferase activity of bone marrow cells, stimulate hormone secretion |
| 10/09/2008 | US20080248992 Inactivated alpha-cobratoxin; neurotoxins affecting neurojunction, ion channels; inactive bioactive polypeptide of anti-immunodeficiency virus immunokine binding to a cellular protein that reduces HIV infection; identification of a biologic anticholinergic agent capable of binding to a cellular protein |
| 10/09/2008 | US20080248991 Chitosan Containing Solution |
| 10/09/2008 | US20080248959 Polypeptide with amino acid sequence including exogenous glycosylate sequence; libraries |
| 10/09/2008 | US20080248576 Genetic Inhibition of double-stranded RNA |
| 10/09/2008 | US20080248571 Method of Production of Artificial Skin |
| 10/09/2008 | US20080248566 Matriptase, a serine protease and its applications |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248544 Methods And Compositions For Grafting Functional Loops Into A Protein |
| 10/09/2008 | US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity |
| 10/09/2008 | US20080248486 Type Pept1 Protein Assay |
| 10/09/2008 | US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 10/09/2008 | US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1 |
| 10/09/2008 | US20080248133 Compositions and methods for nutrition supplementation |
| 10/09/2008 | US20080248132 Compositions and methods for nutrition supplementation |
| 10/09/2008 | US20080248126 preparation of drug-polymer (or oligomer) conjugates; nanoprecipitation |
| 10/09/2008 | US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer |
| 10/09/2008 | US20080248122 preparing microencapsules by forming a microparticle containing active agent, forming a monolayer including charged compound (ionomers, polyelectrolytes) on the microparticle, thus forming a surface-modified microparticle, encapsulating the surface-modified microparticles; sustained release |
| 10/09/2008 | US20080248118 Antioxidant superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase hemeoxygenase, acetyl salicyclic acid, mannitol, captopril, Arg, or pyruvate; vitamins(lycopene, lutein, xeaxanthine, Vitamin A, carotene); administered via carotid artery or juguar vein |
| 10/09/2008 | US20080248116 a mixture of bone morphogenic proteins and transformation growth factors, used for treating bone disorders such as osteoporosis |
| 10/09/2008 | US20080248104 Composition and method for reducing inflammation |
| 10/09/2008 | US20080248103 Melatonin-based composition for improved sleep |
| 10/09/2008 | US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide |
| 10/09/2008 | US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications |
| 10/09/2008 | US20080248095 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 10/09/2008 | US20080248084 Method of treating acute dysfunction of cardiac muscle |
| 10/09/2008 | US20080248082 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 10/09/2008 | US20080248081 Method of treating chronic dysfunction of cardiac muscle |
| 10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
| 10/09/2008 | US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation |
| 10/09/2008 | US20080248056 Immunomodulatory Product Obtained from a Bifidobacterium Culture and Compositions Containing the Same |
| 10/09/2008 | US20080248055 Using glutamate decarboxylase therapeutic for treatment and prevention of pancreatic disorders |
| 10/09/2008 | US20080248053 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 10/09/2008 | US20080248051 Monomethylvaline compounds capable of conjugation to ligands |
| 10/09/2008 | US20080248045 Polypeptides having a triggering nk activity and biological applications |
| 10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
| 10/09/2008 | US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders |
| 10/09/2008 | US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents |
| 10/09/2008 | US20080248033 VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
| 10/09/2008 | US20080248029 Prevention and treatment of amyloidogenic diseases |
| 10/09/2008 | US20080248025 Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions |
| 10/09/2008 | US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference |
| 10/09/2008 | US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein |
| 10/09/2008 | US20080248021 Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment |